Prurigo Nodularis (PN)
ORIGINAL PAPER
A Study to Evaluate the Efficacy and Safety of AK139 in Patients With Prurigo Nodularis.
A Study to Evaluate the Efficacy and Safety of AK139 in Patients With Prurigo Nodularis.
Prurigo Nodularis (PN)
Expected trial readout: 2027-08-01
What the evidence supports so far
Research signals
Classification pending.
What remains unverified
The full methodology, effect size, and limitations still require analyst review.
Company impact remains unverified until a direct economic transmission is established.